IL17A and breast carcinoma: To further confirm the role of CD4+ and CD8+ T cells in human breast cancer development and progression, we assessed CD4+ and CD8+ T cells, as well as IL-17+ and Foxp3+ cells in breast tumor tissues from cancer patients using the immunohistochemical staining (Figure 4A).